The relationship between saphenous coronary bypass graft occlusion and serum gamma-glutamyltransferase activity

Turk Kardiyoloji Dernegi Arsivi

Volumn 38, Issue 5, 2010, Pages 321-326

  Demirkan, Burcu ^a   Güray, Yeşim ^a   Güray, Ümit ^a   Turak, Osman ^a   Hajro, Edjon ^a   Korkmaz, Şule ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

Coronary artery bypass; Gamma glutamyltransferase; Graft occlusion; Saphenous vein transplantation; Vascular

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANGIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME ACTIVITY; EXERCISE TEST; FAMILY HISTORY; FEMALE; FIBRINOGEN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; GRAFT OCCLUSION; HEART CATHETERIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SAPHENOUS VEIN GRAFT; SMOKING; STABLE ANGINA PECTORIS; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; C-REACTIVE PROTEIN; CHOLESTEROL; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GRAFT OCCLUSION, VASCULAR; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RECURRENCE; SAPHENOUS VEIN; URIC ACID;

EID: 79953288931     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005;112:2078-80. (Pubitemid 41475797)
2. Rollason JG, Pincherle G, Robinson D. Serum gamma glutamyl transpeptidase in relation to alcohol consumption. Clin Chim Acta 1972;39:75-80.
3. Pompella A, Emdin M, Passino C, Paolicchi A. The significance of serum gamma-glutamyltransferase in cardiovascular diseases. Clin Chem Lab Med 2004;42:1085-91. (Pubitemid 39481146)
4. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005;112:2130-7. (Pubitemid 41475806)
5. Brenner H, Rothenbacher D, Arndt V, Schuberth S, Fraisse E, Fliedner TM. Distribution, determinants, and prognostic value of gamma-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany. Prev Med 1997;26:305-10. (Pubitemid 27200465)
6. Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, et al. Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl trans-peptidase enzyme activity. Circulation 2004;109:1440.
7. Paolicchi A, Minotti G, Tonarelli P, Tongiani R, De Cesare D, Mezzetti A, et al. Gamma-glutamyl transpeptidase- dependent iron reduction and LDL oxidation-a potential mechanism in atherosclerosis. J Investig Med 1999;47:151-60. (Pubitemid 129541449)
8. Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ, et al. ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). American College of Cardiology/American Heart Association. J Am Coll Cardiol 1999;34:1262-347.
9. Halabi AR, Alexander JH, Shaw LK, Lorenz TJ, Liao L, Kong DF, et al. Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. Am J Cardiol 2005;96:1254-9. (Pubitemid 41505404)
10. Angelini GD, Newby AC. The future of saphenous vein as a coronary artery bypass conduit. Eur Heart J 1989;10:273-80. (Pubitemid 19101341)
11. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995;142:699-708.
12. Jousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000;31:1851-5. (Pubitemid 30620462)
13. van Barneveld T, Seidell JC, Traag N, Hautvast JG. Fat distribution and gamma-glutamyl transferase in relation to serum lipids and blood pressure in 38-year old Dutch males. Eur J Clin Nutr 1989;43:809-18. (Pubitemid 20133707)
14. Daeppen JB, Smith TL, Schuckit MA. Influence of age and body mass index on gamma-glutamyltransferase activity: a 15-year follow-up evaluation in a community sample. Alcohol Clin Exp Res 1998;22:941-4. (Pubitemid 28292484)
15. Yamada Y, Ishizaki M, Kido T, Honda R, Tsuritani I, Yamaya H. Relationship between serum gamma-glutamyl transpeptidase activity and blood pressure in middle-aged male and female non-drinkers. J Hum Hypertens 1990;4:609-14.
16. Umeki S, Hisamoto N, Hara Y. Study on background factors associated with impaired glucose tolerance and/ or diabetes mellitus. Acta Endocrinol 1989;120:729-34. (Pubitemid 19148440)
17. Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesäniemi YA. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med 2000;248:230-8.
18. Colloredo-Mels G, Bettale G, Bellati G, Guanziroli M, Bertone V, Angeli G, et al. Gamma-Glutamyl-transpeptidase in diabetics: a case control study. Clin Chim Acta 1988;175:189-95.
19. Forman HJ, Liu RM, Tian L. Glutathione cycling in oxidative stress. Lung Biol Health Dis 1997;105:99-121.
20. Kappus H, Sies H. Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation. Experientia 1981;37:1233-41. (Pubitemid 12168965)
21. Watanabe M, Taketa K, Izumi M, Nagashima H. Association of gamma-glutamyltransferase with plasma lipoprotein and lipid-protein complex in cholestasis. Hepatogastroenterology 1984;31:204-7. (Pubitemid 14023918)
22. Franzini M, Corti A, Martinelli B, Del Corso A, Emdin M, Parenti GF, et al. Gamma-glutamyltransferase activity in human atherosclerotic plaques-biochemical similarities with the circulating enzyme. Atherosclerosis 2009;202:119-27.
23. Emdin M, Passino C, Michelassi C, Titta F, L'abbate A, Donato L, et al. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 2001;22:1802-7.
24. Emdin M, Passino C, Michelassi C, Donato L, Pompella A, Paolicchi A. Additive prognostic value of gamma-glutamyltransferase in coronary artery disease. Int J Cardiol 2009;136:80-5.
25. Ulus T, Yildirir A, Demirtaş S, Demir O, Sade LE, Bozbaş H, et al. Serum gamma-glutamyl transferase activity: a new marker for stent restenosis? Atherosclerosis 2007;195:348-53.
26. Lee DH, Jacobs DR Jr. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 2005;178:327-30.
27. Pleiner J, Mittermayer F, Schaller G, Marsik C, MacAllister RJ, Wolzt M. Inflammation-induced vaso-constrictor hyporeactivity is caused by oxidative stress. J Am Coll Cardiol 2003;42:1656-62. (Pubitemid 37378449)
28. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001;429:195-207. (Pubitemid 33043996)